即時生物過程拉曼分析儀市場機會、成長促進因素、產業趨勢分析與預測 2024 - 2032 年

Real-Time Bioprocess Raman Analyzer Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年10月21日 | 出版商:

Global Market Insights Inc. | 英文 134 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球即時生物過程拉曼分析儀市場價值為 4.076 億美元，預計 2024 年至 2032 年將以 7.4% 的年複合成長率(CAGR) 成長。成長的市場需求生物製藥的使用以及對生物過程即時監測的需求不斷成長。市場依產品類型分為拉曼分析儀、拉曼探頭和軟體解決方案。 2023 年，拉曼分析儀是領先細分市場，營收為 1.663 億美元。這些分析儀對於生物加工中的即時監測至關重要，並配備了可以準確檢測和測量分子成分的光譜工具。

與探針和軟體等補充產品相比，它們在準確性至關重要的生物製藥製造中具有重要意義，使其成為市場上最重要的部分。在應用方面，即時生物過程拉曼分析儀市場分為生物過程分析和實驗室到過程分析。 2023年，生物過程分析領域佔據了大部分市場佔有率，佔68.9%。拉曼分析儀提供即時資料的能力使製造商能夠監測和控制基本參數，例如細胞密度、營養水平和產品品質。

這種能力可確保生物製品生產遵守監管標準和效率目標。隨著生物製藥複雜性的增加，特別是隨著細胞和基因療法等技術的進步，生物加工中對精確即時分析的需求變得更加重要。北美在 2023 年引領全球市場，營收為 1.524 億美元，預計到 2032 年將達到 2.776 億美元。品質的製造流程並遵守嚴格的法規。美國食品藥物管理局 (FDA) 特別注重透過製程分析技術 (PAT) 框架來提高製程效率和產品品質。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	4.076 億美元
預測值	7.671 億美元
複合年成長率	7.4%

隨著公司尋求最佳化其關鍵的生物製藥工藝，這種監管環境刺激了對即時生物程序分析儀（包括拉曼系統）的需求。

產業生態系統分析
產業影響力
- 成長動力
  - 越來越多採用生物製藥
  - 需要即時過程監控
  - 拉曼光譜技術的進步
  - 對自動化和工業的日益關注
- 產業陷阱與挑戰
  - 初始投資和營運成本高
成長潛力分析
監管環境
- 美國
- 歐洲
技術景觀
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
拉曼分析儀
- 桌上型拉曼分析儀
- 攜帶式拉曼分析儀
- 線上拉曼分析儀
- 線上拉曼分析儀
拉曼探頭
軟體

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
生物過程分析
實驗室到過程分析

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
生物製藥公司
合約製造組織
研究機構
其他最終用戶

第 8 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第 9 章：公司簡介

Agilent Technologies
B&W Tek
Bruker Corporation
Endress+Hauser Group
Horiba Group
Indatech - Chauvin Arnoux Group
MarqMetrix
Merck
Metrohm
METTLER TOLEDO
Real Time analyzers
Renishaw
Sartorius
Thermo Fisher Scientific
Wasatch Photonics

簡介目錄

Product Code: 11927

The Global Real-Time Bioprocess Raman Analyzer Market was valued at USD 407.6 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2032. This growth is fueled by several factors, including the increasing use of biopharmaceuticals and the rising need for real-time monitoring of bioprocesses. The market is segmented by product type into Raman analyzers, Raman probes, and software solutions. In 2023, Raman analyzers were the leading segment, generating revenues of USD 166.3 million. These analyzers are crucial for real-time monitoring in bioprocessing, equipped with spectroscopy tools that can accurately detect and measure molecular compositions.

Their significance in biopharmaceutical manufacturing, where accuracy is vital, makes them the most substantial segment in the market compared to complementary products such as probes and software. Regarding applications, the real-time bioprocess Raman analyzer market is categorized into bioprocess analysis and lab-to-process analysis. The bioprocess analysis segment held the majority of market share in 2023, accounting for 68.9%. The ability of Raman analyzers to deliver real-time data enables manufacturers to monitor and control essential parameters, such as cell density, nutrient levels, and product quality.

This capability ensures that biologics production adheres to regulatory standards and efficiency objectives. As the complexity of biopharmaceuticals increases-particularly with advancements like cell and gene therapies-the demand for precise real-time analysis in bioprocessing becomes even more critical. North America led the global market in 2023, with revenues of USD 152.4 million, and is expected to reach USD 277.6 million by 2032. This region is home to numerous prominent biopharmaceutical companies that heavily rely on real-time monitoring technologies, including Raman analyzers, to maintain high-quality manufacturing processes and comply with stringent regulations. The U.S. Food and Drug Administration (FDA) is particularly focused on enhancing process efficiency and product quality through the Process Analytical Technology (PAT) framework.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$407.6 Million
Forecast Value	$767.1 Million
CAGR	7.4%

This regulatory environment is stimulating the demand for real-time bioprocess analyzers, including Raman systems, as companies seek to optimize their critical biopharmaceutical processes.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing adoption of biopharmaceuticals
  - 3.2.1.2 Need for real-time process monitoring
  - 3.2.1.3 Advancements in Raman spectroscopy technology
  - 3.2.1.4 Rising focus on automation and industry
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High initial investment and operational costs
3.3 Growth potential analysis
3.4 Regulatory landscape
- 3.4.1 U.S.
- 3.4.2 Europe
3.5 Technology landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Raman analyzers
- 5.2.1 Benchtop raman analyzers
- 5.2.2 Portable raman analyzers
- 5.2.3 On-line raman analyzers
- 5.2.4 In-line raman analyzers
5.3 Raman probes
5.4 Software

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Bioprocess analysis
6.3 Lab to process analysis

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Biopharmaceutical companies
7.3 Contract manufacturing organizations
7.4 Research organizations
7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE